dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
imfinzi 120mg/2.4ml i.v. inf. vial
ايمفينزي 120مجم2.4مل محلول وريد فيال
durvalumab · 120mg/2.4ml
14300EGP
Available
Active ingredient
durvalumab
Strength
120mg/2.4ml
Form
vial
Manufacturer
astra zeneca
Route
injection

Uses

Used in the treatment of several cancers including non-small cell lung cancer, small cell lung cancer, biliary tract cancer, and other approved malignancies.

Do not use if

No specific contraindications are listed, except known hypersensitivity to the product components.

Side effects

Common adverse effects include fatigue, decreased appetite, cough, rash, diarrhea, and infusion-related reactions.

Warnings

May cause severe or fatal immune-mediated reactions affecting lungs, liver, intestines, endocrine organs, and other tissues.

How it works

A PD-L1 blocking monoclonal antibody that enhances antitumor immune responses by restoring T-cell activity.

Storage

Store refrigerated at 2–8°C and protect from freezing.